Market Tracker

06/23 5:16pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.573
Delayed Data
As of Jun 23
 -0.0089 / -1.53%
Today’s Change
0.28
Today|||52-Week Range
0.77
+85.80%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.58
Today’s open0.58
Day’s range0.57 - 0.59
Volume746,223
Average volume (3 months)2,615,248
Market cap$170.6M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+64.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc-0.03-1.90%
STDYSteadymed Ltd+0.10+1.52%
KURAKura Oncology Inc-0.05-0.63%
FOMXFoamix Pharmaceutica...+0.14+3.10%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateJuly 17, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts